Full Name
Adam Abramowitz
Title
Managing Director & Head of Healthcare
Company
Intrepid Investment Bankers
Bio
Adam has more than 22 years of investment banking experience in the middle market. He
joined Intrepid as Vice President and Founding Principal in 2010, after nearly a decade of
focusing on middle-market mergers and acquisitions at Barrington Associates and Wells
Fargo Securities. Adam has executed transactions involving private and public companies in
a wide variety of industries, including healthcare, consumer products, business services and
industrial manufacturing. In addition to executing transactions, he’s actively involved in the
management, growth, and development of the firm.

Adam leads Intrepid’s Healthcare Group, which has grown to be one of the most active in the
Western U.S. Adam advises companies in the behavioral healthcare, life sciences,
healthcare technology, physician practice management and outsourced healthcare services
spaces working with dynamic entrepreneurs. Recently, the Los Angeles Business Journal
named Adam the “Healthcare Trusted Advisor of the Year” and a “Leader of Influence in
Investment Banking.”

Some of his notable recent transactions include the sale of Your Behavioral Health (Clear
Recovery Center, Neuro Wellness Spa and New Life House), a leading mental health and
addiction treatment services platform, to private equity firm Comvest Partners; the
acquisition of Right Choice In-Home Care, one of the largest independent IDD in-home care
providers in California, by Prime Providers, a leading provider of home-based healthcare
services including private duty nursing and ABA therapy; the sale of Connetics USA, a
leading international nurse recruitment business, to AMN Healthcare NYSE:AMN); the sale of
Apostrophe, a leading tele-dermatology platform, on its sale to Hims & Hers Health, Inc.
(NYSE: HIMS), a leading multi-specialty telehealth platform; and the sale of Mosaic
Laboratories, a specialized CRO/bioanalytical lab serving pharma companies, to CellCarta, a
portfolio company of Arsenal Capital. In addition, Adam helped lead the groundbreaking sale
of Ambry Genetics to Konica Minolta in a deal valued at $1 billion. Adam is highly regarded
among his clients and peers for the tenacity with which he approaches deals and his
proactivity to bring creative solutions to challenging deals.

Adam previously served on the Board of Directors for ACG Los Angeles Chapter. In particular,
he has a passion for helping young professionals build their careers. In 2012, Adam created
and spearheaded the launch of the ACG Rising Stars Program. This has been one of ACG’s
most successful programs that has been oversubscribed with participants.

In June 2021, Adam was awarded the JVS SoCal Generation Impact Award and in 2019 he
was selected as Vice Chair of the Emerging Leaders Program for JVS SoCal as he also serves
on its Board of Directors. Adam has a passion for helping those who need assistance to find
and develop critical skills to gain meaningful employment.

Adam is a passionate Washington professional football fan who remains loyal, despite the
team’s challenges on the field. On his daily run each morning, he enjoys listening to various
sports and entertainment podcasts.
Adam Abramowitz